Matthew Shea's Stock Coverage
| ALHCAlignment Healthcare | Oct 30, 2026 | HOLD | Reiterated | ― | 1Ratings | ― | ― | |
| CLOVClover Health Investments | Oct 28, 2026 | BUY | Initiated | $6.00 | 1Ratings | -4.30% | ||
| STLNStarling Oncology Institute | Oct 14, 2026 | BUY | Reiterated | $9.00 | 11Ratings | +63.23% | ||
| ASTHAstrana Health | Aug 07, 2026 | BUY | Reiterated | $41.00 | 4Ratings | +22.68% | ||
| EVHEvolent Health | Aug 06, 2026 | BUY | Reiterated | $5.00 | 12Ratings | -30.39% | ||
| AGLAgilon Health | Aug 06, 2026 | HOLD | Reiterated | ― | 9Ratings | ― | ― | |
| PRVAPrivia Health Group | May 07, 2026 | BUY | Reiterated | $30.00 | 7Ratings | -4.06% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Matthew Shea activity FAQ
What is the performance of Matthew Shea's recommendations?
The percentage of profitable recommendations made by Matthew Shea is 53.33%, and the average return per transaction is 11.70%.
What stocks does Matthew Shea cover?
Matthew Shea mostly covers Alignment Healthcare, Clover Health Investments, Starling Oncology Institute stocks.
What was Matthew Shea's most profitable rating?
Matthew Shea’s most profitable rating was a buy on Starling Oncology Institute stock on Mar 09, 2026. The return on the trade was 143.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here